MobiHealth News June 30, 2021
The new acquisition is expected to help the company grow out its diagnostic capabilities.
This morning, direct-to-consumer virtual health company Ro announced its plans to buy at-home diagnostic company Kit for an undisclosed sum. This marks the company’s second acquisition in two months.
Kit developed a system that allows patients to self-administer an at-home sample collection. Before taking the sample, patients are asked to download the corresponding app, which contains step-by-step videos on how to administer the test and offers on-demand support. The tests include finger-prick blood assays, blood pressure tests and weight measurement tools.
The patient then mails the sample away to a lab. Once the lab results are in, patients get a notification on their Kit app, where...